Neuren Pharmaceuticals Gestione
Gestione criteri di controllo 3/4
Neuren Pharmaceuticals Il CEO è Jon Pilcher, nominato in May2020, e ha un mandato di 4.5 anni. la retribuzione annua totale è A$ 1.36M, composta da 40.2% di stipendio e 59.8% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.31% delle azioni della società, per un valore di A$ 6.59M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.4 anni e 6.3 anni.
Informazioni chiave
Jon Pilcher
Amministratore delegato
AU$1.4m
Compenso totale
| Percentuale dello stipendio del CEO | 40.2% |
| Mandato del CEO | 4.5yrs |
| Proprietà del CEO | 0.3% |
| Durata media del management | 4.4yrs |
| Durata media del Consiglio di amministrazione | 6.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
New Forecasts: Here's What Analysts Think The Future Holds For Neuren Pharmaceuticals Limited (ASX:NEU)
Nov 11
Neuren Pharmaceuticals Limited's (ASX:NEU) Shares Climb 26% But Its Business Is Yet to Catch Up
Nov 08Calculating The Intrinsic Value Of Neuren Pharmaceuticals Limited (ASX:NEU)
Oct 24Neuren Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Aug 29Pinning Down Neuren Pharmaceuticals Limited's (ASX:NEU) P/S Is Difficult Right Now
Aug 14Here's Why We Think Neuren Pharmaceuticals (ASX:NEU) Might Deserve Your Attention Today
May 31Getting In Cheap On Neuren Pharmaceuticals Limited (ASX:NEU) Is Unlikely
May 03An Intrinsic Calculation For Neuren Pharmaceuticals Limited (ASX:NEU) Suggests It's 41% Undervalued
Apr 01Forecast: Analysts Think Neuren Pharmaceuticals Limited's (ASX:NEU) Business Prospects Have Improved Drastically
Mar 05Here's Why Neuren Pharmaceuticals (ASX:NEU) Has Caught The Eye Of Investors
Mar 02Neuren Pharmaceuticals Limited's (ASX:NEU) 51% Jump Shows Its Popularity With Investors
Dec 18Need To Know: Analysts Are Much More Bullish On Neuren Pharmaceuticals Limited (ASX:NEU) Revenues
Sep 02Calculating The Fair Value Of Neuren Pharmaceuticals Limited (ASX:NEU)
Aug 31This Just In: Analysts Are Boosting Their Neuren Pharmaceuticals Limited (ASX:NEU) Outlook for This Year
Mar 03Neuren Pharmaceuticals (ASX:NEU) Is In A Strong Position To Grow Its Business
Jan 07We Think Neuren Pharmaceuticals (ASX:NEU) Can Easily Afford To Drive Business Growth
Sep 06Companies Like Neuren Pharmaceuticals (ASX:NEU) Can Afford To Invest In Growth
May 31We're Not Worried About Neuren Pharmaceuticals' (ASX:NEU) Cash Burn
Feb 03Here's Why We're Not At All Concerned With Neuren Pharmaceuticals' (ASX:NEU) Cash Burn Situation
Aug 06We Think Neuren Pharmaceuticals (ASX:NEU) Can Easily Afford To Drive Business Growth
May 05Independent Non-Executive Chairman Patrick Donald Davies Just Bought 21% More Shares In Neuren Pharmaceuticals Limited (ASX:NEU)
Feb 19Have Insiders Been Selling Neuren Pharmaceuticals Limited (ASX:NEU) Shares This Year?
Jan 04
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | AU$117m |
| Mar 31 2024 | n/a | n/a | AU$137m |
| Dec 31 2023 | AU$1m | AU$549k | AU$157m |
| Sep 30 2023 | n/a | n/a | AU$106m |
| Jun 30 2023 | n/a | n/a | AU$55m |
| Mar 31 2023 | n/a | n/a | AU$28m |
| Dec 31 2022 | AU$546k | AU$396k | AU$184k |
| Sep 30 2022 | n/a | n/a | -AU$3m |
| Jun 30 2022 | n/a | n/a | -AU$7m |
| Mar 31 2022 | n/a | n/a | -AU$7m |
| Dec 31 2021 | AU$432k | AU$203k | -AU$8m |
Compensazione vs Mercato: La retribuzione totale di Jon ($USD 890.72K ) è inferiore alla media delle aziende di dimensioni simili nel mercato Australian ($USD 1.47M ).
Compensazione vs guadagni: La retribuzione di Jon è aumentata di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Jon Pilcher
4.5yrs
Mandato
AU$1,364,404
Compensazione
Mr. Jonathan Charles Pilcher, also known as Jon, BSc (Hons), ACA, FCA serves as Managing Director & Executive Director at Neuren Pharmaceuticals Limited since June 14, 2021. He had been a Company Secretary...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, MD & Executive Director | 4.5yrs | AU$1.36m | 0.31% A$ 6.6m | |
| CFO & Company Secretary | 4.3yrs | Nessun dato | Nessun dato | |
| Chief Science Officer | 20.8yrs | Nessun dato | Nessun dato | |
| Vice President of Corporate Development | no data | Nessun dato | Nessun dato | |
| Chief Medical Officer | 2.3yrs | Nessun dato | Nessun dato |
4.4yrs
Durata media
Gestione esperta: Il team dirigenziale di NEU è considerato esperto (durata media dell'incarico 4.4 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, MD & Executive Director | 3.4yrs | AU$1.36m | 0.31% A$ 6.6m | |
| Independent Non-Executive Director | 6.3yrs | AU$75.00k | 0.023% A$ 496.2k | |
| Independent Non-Executive Director | 6.3yrs | AU$75.00k | 0.023% A$ 490.7k | |
| Independent Non-Executive Chairman | 6.3yrs | AU$125.00k | 0.21% A$ 4.4m | |
| Independent Non-Executive Director | 1.7yrs | AU$62.50k | 0.017% A$ 354.1k |
6.3yrs
Durata media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di NEU sono considerati esperti (durata media dell'incarico 6.3 anni).